Bacterial promotion of bisphosphonate-induced osteonecrosis in Wistar rats

International Journal of Oral and Maxillofacial Surgery

Volumn 42, Issue 11, 2013, Pages 1481-1487

  Tsurushima, H ^a   Kokuryo, S ^a,b   Sakaguchi, O ^a   Tanaka, J ^a   Tominaga, K ^a  

^a KYUSHU DENTAL COLLEGE   (Japan)

^b Kyushu University   (Japan)

Author keywords

bisphosphonate; bisphosphonate related osteonecrosis of the jaw; BRONJ; model; rat

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; FREUND ADJUVANT; SODIUM CHLORIDE; ZOLEDRONIC ACID;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BISPHOSPHONATE RELATED OSTEONECROSIS; BONE NECROSIS; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMUR; HISTOPATHOLOGY; JAW OSTEONECROSIS; MALE; MOUSE; NONHUMAN;

BISPHOSPHONATE; BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW; BRONJ; MODEL; RAT;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANIMALS; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE MARROW; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; FEMUR; IMIDAZOLES; MALE; MANDIBLE; PASTEURELLACEAE INFECTIONS; RATS; RATS, WISTAR;

EID: 84887072242     PISSN: 09015027     EISSN: 13990020     Source Type: Journal    
DOI: 10.1016/j.ijom.2013.06.011     Document Type: Article

References (20)

1. G.A. Rodan, and H.A. Fleisch Bisphosphonates: mechanisms of action J Clin Invest 97 1996 2692 2696
2. R.G. Russell, Z. Xia, J.E. Dunford, U. Oppermann, A. Kwaasi, P.A. Hulley, K.L. Kavanagh, J.T. Triffitt, M.W. Lundy, R.J. Phipps, B.L. Barnett, F.P. Coxon, M.J. Rogers, N.B. Watts, and F.H. Ebetino Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy Ann N Y Acad Sci 1117 2007 209 257
3. L.S. Rosen, D.H. Gordon, W. Dugan Jr., P. Major, P.D. Eisenberg, L. Provencher, M. Kaminski, J. Simeone, J. Seaman, B.L. Chen, and R.E. Coleman Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion Cancer 100 2004 36 43
4. N. Kohno, K. Aogi, H. Minami, S. Nakamura, T. Asaga, Y. Iino, T. Watanabe, C. Goessl, Y. Ohashi, and S. Takashima Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial J Clin Oncol 23 2005 3314 3321
5. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws. A growing epidemic J Oral Maxillofac Surg 61 2003 1115 1118
6. C.A. Migliorati Bisphosphonates and oral cavity avascular bone necrosis J Clin Oncol 21 2003 4253 4254
7. S.L. Ruggiero, T.B. Dodson, L.A. Assael, R. Landesberg, R.E. Marx, and B. Mehrotra American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws - 2009 update J Oral Maxillofac Surg 67 2009 2 12
8. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the, jaws J Oral Maxillofac Surg 65 2007 369 376
9. T. Mavrokokki, A. Cheng, B. Stein, and A. Goss Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia J Oral Maxillofac Surg 65 2007 415 423
10. R.E. Marx, Y. Sawatari, M. Fortin, and V. Broumand Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment J Oral Maxillofac Surg 63 2005 1567 1575
11. T. Yoneda, H. Hagino, T. Sugimoto, H. Ohta, S. Takahashi, S. Soen, A. Taguchi, S. Toyosawa, T. Nagata, and M. Urade Bisphosphonate-related osteonecrosis of the jaw: position paper from the allied task force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons J Bone Miner Metab 28 2010 365 383
12. R.E. Marx, J.E. Cillo Jr., and J.J. Ulloa Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment J Oral Maxillofac Surg 65 2007 2397 2410
13. S.S. Huja, and F.M. Beck Bone remodeling in maxilla, mandible, and femur of young dogs Anat Rec 291 2007 1 5
14. L.K. McCauley, and X. Li Distinguishing features of the oral cavity and its predisposition to osteonecrosis J Musculoskelet Neuronal Interact 7 2007 356 357
15. A. Labrinidis, S. Hay, V. Liapis, V. Ponomarev, D.M. Findlay, and A. Evdokiou Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model Clin Cancer Res 15 2009 3451 3461
16. M.R. Allen, and D.B. Burr Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment J Oral Maxillofac Surg 66 2008 987 994
17. Y. Kobayashi, T. Hiraga, A. Ueda, L. Wang, M.M. Nakano, K. Hata, H. Yatani, and T. Yoneda Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice J Bone Miner Metab 28 2010 165 175
18. A.B. Cankaya, M.A. Erdem, S.C. Isler, S. Demircan, M. Soluk, C. Kasapoglu, and C.K. Oral Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws in an experimental rat model Int J Med Sci 8 2011 667 672
19. B. Pan, A.N. Farrugia, L.B. To, D.M. Findlay, J. Green, K. Lynch, and A.C. Zannettino The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro Bone 34 2004 112 123
20. E. Shimizu, J. Tamasi, and N.C. Partridge Alendronate affects osteoblast functions by crosstalk through EphrinB1-EphB J Dent Res 91 2012 268 274